Literature DB >> 16158288

Immunohistochemical demonstration of histone H1(0) in human breast carcinoma.

Nora N Kostova1, Ljuba N Srebreva, Angel D Milev, Olga G Bogdanova, Ingemar Rundquist, Herbert H Lindner, Dimiter V Markov.   

Abstract

Histone H1(0) is a linker histone subvariant present in tissues of low proliferation rate. It is supposed to participate in the expression and maintenance of the terminal differentiation phenotype. The aim of this work was to study histone H1(0) distribution in human breast carcinoma and its relationship with the processes of proliferation and differentiation. Most of the cells in carcinomas of moderate and high level of differentiation expressed histone H1(0) including cells invading connective and adipose tissues. In low differentiated tumours, the number of H1(0) expressing cells was considerably lower. Staining of myoepithelial cells, when seen, and of stromal fibroblasts was variable. The metastatic malignant cells in the lymph nodes also accumulated H1(0) but lymphocytes were always negative. All immunopositive malignant cells exhibited signs of polymorphism. Double H1(0)/Ki-67 staining showed that the growth fraction in more differentiated tumours belonged to the H1(0)-positive cells, while in poorly differentiated carcinomas it also included a cell subpopulation not expressing H1(0). If expressed, p27Kip1 was always found in H1(0)-positive cells. These findings are inconsistent with the widespread view that histone H1(0) is expressed only in terminally differentiated cells. Rather, they suggest that the protein is expressed in cells in a prolonged intermitotic period irrespective of their level of differentiation. Double H1(0)/Ki-67 immunostaining could be a useful tool in studying the growth fraction in tumours.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16158288     DOI: 10.1007/s00418-005-0052-6

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  52 in total

1.  Immunohistochemical assessment of proliferative activity in mammary adenomyoepithelioma.

Authors:  M Koyama; H Kurotaki; N Yagihashi; S Aizawa; M Sugai; Y Kamata; T Oyama; S Yagihashi
Journal:  Histopathology       Date:  1997-08       Impact factor: 5.087

2.  Chromosomal proteins in hepatocarcinogenesis.

Authors:  R Tsanev; D Hadjiolov
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978

3.  Flow cytofluorimetric determination of protein distribution throughout the cell cycle.

Authors:  S Khochbin; A Chabanas; P Albert; J J Lawrence
Journal:  Cytometry       Date:  1989-07

4.  Appearance of a chromatin protein during the erythroid differentiation of Friend virus-transformed cells.

Authors:  F Keppel; B Allet; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  Changes in chromatin proteins during liver regeneration.

Authors:  W T Garrard; J Bonner
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

6.  Lysine-rich histone phosphorylation. A positive correlation with cell replication.

Authors:  R Balhorn; R Chalkley; D Granner
Journal:  Biochemistry       Date:  1972-03-14       Impact factor: 3.162

7.  Selective in vitro methylation of rat chromatin associated histone after partial hepatectomy.

Authors:  W B Benjamin
Journal:  Nat New Biol       Date:  1971-11-03

8.  The histone H1 complements of dividing and nondividing cells of the mouse.

Authors:  R W Lennox; L H Cohen
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

9.  Differences in the condensation of chromatin by individual subfractions of histone H1: implications for the role of H1(0) in the structural organization of chromatin.

Authors:  C Marion; J Roche; B Roux; C Gorka
Journal:  Biochemistry       Date:  1985-11-05       Impact factor: 3.162

10.  A group of H1 histone satellite acid-soluble non-histone chromatin proteins.

Authors:  Z A Medvedev; M N Medvedeva
Journal:  FEBS Lett       Date:  1980-03-24       Impact factor: 4.124

View more
  9 in total

Review 1.  Recent progress in histochemistry and cell biology: the state of the art 2005.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2005-11-11       Impact factor: 4.304

Review 2.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

3.  Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report.

Authors:  Mazdak Momeni; Tamara Kalir; Sara Farag; Linus Chuang; David Fishman; David E Burstein
Journal:  Cell Oncol (Dordr)       Date:  2014-07-15       Impact factor: 6.730

4.  Histone variant innovation in a rapidly evolving chordate lineage.

Authors:  Alexandra Moosmann; Coen Campsteijn; Pascal Wtc Jansen; Carole Nasrallah; Martina Raasholm; Henk G Stunnenberg; Eric M Thompson
Journal:  BMC Evol Biol       Date:  2011-07-15       Impact factor: 3.260

Review 5.  Linker Histone in Diseases.

Authors:  Xin Ye; ChuanLin Feng; Tian Gao; Guanqun Mu; Weiguo Zhu; Yang Yang
Journal:  Int J Biol Sci       Date:  2017-07-18       Impact factor: 6.580

Review 6.  H1.0 Linker Histone as an Epigenetic Regulator of Cell Proliferation and Differentiation.

Authors:  Carlo Maria Di Liegro; Gabriella Schiera; Italia Di Liegro
Journal:  Genes (Basel)       Date:  2018-06-20       Impact factor: 4.096

Review 7.  Histone Variants: Guardians of Genome Integrity.

Authors:  Juliette Ferrand; Beatrice Rondinelli; Sophie E Polo
Journal:  Cells       Date:  2020-11-05       Impact factor: 6.600

8.  Histone H1x is highly expressed in human neuroendocrine cells and tumours.

Authors:  Julia Warneboldt; Florian Haller; Olaf Horstmann; Bernhard C Danner; László Füzesi; Detlef Doenecke; Nicole Happel
Journal:  BMC Cancer       Date:  2008-12-24       Impact factor: 4.430

9.  Label-Free Mass Spectrometry-Based Quantification of Linker Histone H1 Variants in Clinical Samples.

Authors:  Roberta Noberini; Cristina Morales Torres; Evelyn Oliva Savoia; Stefania Brandini; Maria Giovanna Jodice; Giovanni Bertalot; Giuseppina Bonizzi; Maria Capra; Giuseppe Diaferia; Paola Scaffidi; Tiziana Bonaldi
Journal:  Int J Mol Sci       Date:  2020-10-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.